{"c":"H3038","name":"MOLINA HEALTHCARE OF CALIFORNIA","parent":"Molina Healthcare, Inc.","members":29055,"m":[["Breast Cancer Screening","3","2","70%",1],["Colorectal Cancer Screening","4","3","75%",1],["Annual Flu Vaccine","3","3","61%",0],["Improving or Maintaining Physical Health","Plan too new to be measured","Plan too new to be measured","Plan too new to be measured",null],["Improving or Maintaining Mental Health","Plan too new to be measured","Plan too new to be measured","Plan too new to be measured",null],["Monitoring Physical Activity","3","Plan too new to be measured","51%",null],["Special Needs Plan (SNP) Care Management","3","2","67%",1],["Care for Older Adults - Medication Review","3","3","90%",0],["Care for Older Adults - Functional Status Assessment","3",null,"86%",null],["Osteoporosis Management in Women who had a Fracture","1","1","27%",0],["Diabetes Care - Eye Exam","4","4","83%",0],["Diabetes Care - Blood Sugar Controlled","3","3","83%",0],["Kidney Health Evaluation for Patients with Diabetes","4","4","75%",0],["Controlling High Blood Pressure","3","3","80%",0],["Reducing the Risk of Falling","Not enough data available","Plan too new to be measured","Not enough data available",null],["Improving Bladder Control","Not enough data available","Plan too new to be measured","Not enough data available",null],["Plan All-Cause Readmissions","3","2","11%",1],["Statin Therapy for Patients with Cardiovascular Disease","3","3","87%",0],["Transitions of Care","4","1","70%",3],["Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions","1","1","50%",0],["Getting Needed Care","1","1","76",0],["Getting Appointments and Care Quickly","Not enough data available","Not enough data available","Not enough data available",null],["Customer Service","2","3","88",-1],["Rating of Health Care Quality","4","2","87",2],["Rating of Health Plan","3","3","86",0],["Care Coordination","Not enough data available","Not enough data available","Not enough data available",null],["Complaints about the Health Plan","3","3","0.56",0],["Members Choosing to Leave the Plan","4","4","17%",0],["Health Plan Quality Improvement","4","Not enough data available","Medicare shows only a Star Rating for this topic",null],["Plan Makes Timely Decisions about Appeals","4","4","99%",0],["Reviewing Appeals Decisions","4","4","99%",0],["Call Center - Foreign Language Interpreter and TTY Availability","4","5","98%",-1],["Complaints about the Drug Plan","3","3","0.56",0],["Drug Plan Quality Improvement","1","Not enough data available","Medicare shows only a Star Rating for this topic",null],["Rating of Drug Plan","4","4","87",0],["Getting Needed Prescription Drugs","Not enough data available","Not enough data available","Not enough data available",null],["MPF Price Accuracy","4","5","99",-1],["Medication Adherence for Diabetes Medications","2","4","88%",-2],["Medication Adherence for Hypertension (RAS antagonists)","3","3","89%",0],["Medication Adherence for Cholesterol (Statins)","2","3","87%",-1],["Statin Use in Persons with Diabetes (SUPD)","4","4","91%",0],["Concurrent Use of Opioids and Benzodiazepines (COB)","5",null,"6%",null],["Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH)","3",null,"10%",null]],"src":"CMS 2027 Star Ratings Data Tables (Oct 8, 2026), Measure Stars and Measure Data; CMS 2026 Star Ratings Data Tables (Oct 8, 2025); CMS CPSC enrollment October 2026"}